Lactoferrin exerts its biological activities by interacting with receptors on target cells, 2 including LDL receptor-related protein-1 (LRP-1/CD91), intelectin-1 (Omentin-1), and 3
Lactoferrin is an iron-binding glycoprotein present in external secretions and secondary 2 granules of neutrophils. Lactoferrin contributes to host defense through its anti-bacterial 3 and immune modulatory activities (Legrand 2012; Alexander et al. 2012 ). In addition, 4 lactoferrin can regulate the growth and differentiation of many types of mammalian 5 cells (Alexander et al. 2012) . The sulfated chain of cell surface proteoglycans is 6 regarded as the primary lactoferrin-binding site (Legrand et al. 2006) . Following initial 7 binding, lactoferrin interacts with specific cell surface receptors and activates 8 intracellular signaling pathways, such as the ERK1/2 and PI3K/Akt signaling pathways. 9
The effect of lactoferrin binding depends on the types and distribution of receptors on 10 the cell surface (Suzuki et al. 2005) . 11
Low-density lipoprotein receptor-related protein-1 (LRP-1, also known as CD91) is a 12 ubiquitously expressed receptor that belongs to the low-density lipoprotein (LDL) 13 receptor family (May et al. 2005) . LRP-1 recognizes more than 40 different ligands, 14 including lactoferrin. LRP-1 participates in hepatocyte uptake and clearance of 15 lactoferrin from circulation (Willnow et al. 1992 ). In addition, LRP-1 is a potent 16 lactoferrin signaling receptor that converts lactoferrin binding to activation of the 17 ERK1/2 signaling pathway in fibroblasts, osteoblasts, keratinocytes, and adipocytes 18 (Takayama et al. 2003; Grey et al. 2004; Tang et al. 2010; Ikoma-Seki et al. 2015) . containing human CXCR4 were diluted with ELISA diluent solution at 4 µg/ml, then 1 added to the wells and incubated at room temperature for 1 hr. Biotinylated null 2 lipoparticles (without a specific receptor) were used as reference samples to account for 3 any nonspecific binding. The wells were washed five times with TBS-T and incubated 4 for 1 hr at room temperature with streptavidin-HRP at a dilution of 1:1,000 in TBS-T. 5
After five washes with TBS-T, TMB was added for development of color, and the 6 absorbance was read at 450 nm. 7 8
Cell culture 9
HaCaT cells were maintained in high-glucose DMEM supplemented with 10% fetal 10 bovine serum (FBS), 100 U/ml penicillin, and 100 U/ml streptomycin in an atmosphere 11 of 5% CO 2 and 95% air at 37°C. Caco-2 cells were maintained in MEM supplemented 12 with 10% FBS, 1% NEAA, 100 U/ml penicillin, and 100 U/ml streptomycin in an 13 atmosphere of 5% CO 2 and 95% air at 37°C. 14 15
Cycloheximide chase assay 16
HaCaT keratinocytes were treated with cycloheximide (5 µg/ml) for 15 min, 17 followed by stimulation with bovine lactoferrin (10 µM) or SDF-1 (100 ng/ml) for 3 or 18 6 hr. At each time point, cells were washed twice by ice-cold PBS and lysed in RIPA 19 buffer supplemented with 1% protease inhibitor cocktail. 20
21

Crosslinking 22
Serum-starved HaCaT keratinocytes (10 7 cells) were placed on ice and cooled by 23 the addition of ice-cold PBS. After three washes with ice-cold PBS, cells were 24 incubated with bovine lactoferrin (10 µM) or SDF-1 (100 ng/ml) for 60 min at 4°C. 25
After washing with ice-cold PBS, cells were treated with 1 mM BS3 crosslinker for 30 26 min at 4°C with continuous rocking. The crosslinking reaction was terminated by the 27 addition of 0.02 volume of 1 M Tris-HCl (pH 7.4) for 30 min at 4°C. After washing 28 with ice-cold PBS, cells were lysed in RIPA buffer supplemented with 1% protease 29 inhibitor cocktail. Cell lysates were subjected to immunoprecipitation using 30 anti-CXCR4 antibody. 31 D r a f t Serum-starved HaCaT keratinocytes were placed on ice and treated with MG132 1 (10 µM) for 6 hr. Cells were stimulated with bovine lactoferrin (10 µM) or SDF-1 (100 2 ng/ml) for 30 min at 4°C. After washing with ice-cold PBS, cells were lysed in RIPA 3 buffer supplemented with 1% protease inhibitor cocktail. Cell lysates were subjected to 4 immunoprecipitation using anti-CXCR4 antibody. 5 6
Immunoprecipitation 7
HaCaT cells were lysed in RIPA buffer supplemented with 1% protease inhibitor 8 cocktail and centrifuged for 15 min at 15,000 × g. Protein extract containing 400 µg of 9 protein was precleared by incubation with 20 µg of Protein A/G agarose for 60 min. 
18
Western blotting 19
Cells were harvested in RIPA buffer to yield cell lysates. To assess protein 20 expression, cell lysates were resolved by 10% sodium dodecyl sulfate polyacrylamide 21 gel electrophoresis and electrically transferred to a PVDF membrane. Subsequently, the 22 membrane was treated with blocking reagent (Tris-buffered saline containing 0.1% 23
Tween-20 and 5% skim milk) for 2 hr at room temperature. Blocked membranes were 24 incubated with primary antibody, followed by incubation with HRP-conjugated 25 secondary antibody. Immunoreactivity was detected using Western blotting detection 26
reagents. 27 28
Data analysis 29
Data are presented as means ± standard deviation. Unpaired two-tailed t-test was 30 applied to determine statistical significance (p < 0.05) for each data set. 31 D r a f t CXCR4-containing lipoparticles and null lipoparticles (without a specific receptor) were 3 incubated with bovine lactoferrin immobilized to polystyrene wells, the binding of 4 CXCR4-containing lipoparticles was significantly higher (1.7-fold) than that of null 5 lipoparticles ( Fig. 1) . When CXCR4-containing and null lipoparticles were incubated 6 with uncoated polystyrene wells, only trace amounts of lipoparticles attached to the 7 wells. SDF-1 was previously reported to interact with the extracellular domain of 8 CXCR4 (Brelot et al. 2000) . Therefore, we investigated the ability of SDF-1 to compete 9 with lactoferrin for interaction with CXCR4-containing lipoparticles. CXCR4 10 interaction with bovine lactoferrin was not inhibited by SDF-1 (100 ng/ml), suggesting 11 that bovine lactoferrin interacts with CXCR4 using a different mechanism than SDF-1. 12 13
Role of CXCR4 on lactoferrin-induced Akt phosphorylation 14
To determine whether CXCR4 is involved in lactoferrin-induced activation of 15 intracellular signaling pathways, we assessed the effect of AMD3100, a small molecule 16 inhibitor of CXCR4, on lactoferrin-induced Akt phosphorylation in Caco-2 human 17 intestinal cells and HaCaT human keratinocytes. Treatment of serum-starved Caco-2 18 cells with SDF-1 (100 ng/ml) or bovine lactoferrin (10 µM) led to Akt phosphorylation 19 within 5 min, and both SDF-1-and lactoferrin-induced Akt phosphorylation was 20 inhibited by AMD3100 (Fig. 2a) . In HaCaT keratinocytes, both SDF-1 and bovine 21 lactoferrin induced Akt and ERK 1/2 phosphorylation. However, pretreatment with 22 AMD3100 inhibited lactoferrin-induced Akt phosphorylation (Fig. 2b) . The inhibitory 23 effect of AMD3100 was comparable to that of LY294002, which downregulates Akt 24 phosphorylation. Interestingly, AMD3100 enhanced ERK1/2 phosphorylation in 25 lactoferrin treated HaCaT keratinocytes (Fig. 2b) . To exclude any off-target effects of 26 AMD3100, we investigated the effects of a CXCR4-neutralizing antibody on 27 lactoferrin-induced Akt phosphorylation. As shown in Figure 2c , lactoferrin-induced 28 Akt phosphorylation was inhibited by pretreatment of HaCaT keratinocytes with 29 CXCR4-neutralizing antibody (10 µg/ml). These observations suggest that CXCR4 is 30 involved in lactoferrin-induced Akt phosphorylation in Caco-2 and HaCaT cells. 31 D r a f t
As with other C-X-C-type chemokine receptors, ligand binding of CXCR4 results 1 in dimerization of the receptors (Vila-Coro et al. 1999; Busillo and Benovic 2007) . 2 Therefore, we investigated whether bovine lactoferrin triggers the dimerization of 3 CXCR4 in HaCaT keratinocytes. BS3-mediated crosslinking was performed in 4 keratinocytes stimulated with bovine lactoferrin (10 µM). Immunoprecipitation with an 5 anti-CXCR4 antibody (clone 44708) followed by Western blotting using anti-CXCR4 6 antibody (clone 2F1) revealed an 80 kDa band in cells stimulated with bovine 7 lactoferrin (Fig. 3a) . The size of this band was close to the expected molecular weight 8 of a CXCR4 dimer, suggesting that binding of bovine lactoferrin triggers dimerization 9 of CXCR4. 10 11
Lactoferrin-induced tyrosine phosphorylation of CXCR4 12
The SDF-1/CXCR4 interaction stimulates tyrosine phosphorylation of CXCR4, 13
followed by the activation of the JAK/STAT pathway (Vila-Coro et al. 1999; Busillo 14 and Benovic 2007) . To evaluate the effect of bovine lactoferrin on tyrosine 15 phosphorylation of CXCR4, serum-starved HaCaT keratinocytes were stimulated with 16 bovine lactoferrin (10 µM) for 5 min. HaCaT keratinocytes were also stimulated with 17 SDF-1 (100 ng/ml) as a positive control. Immunoprecipitation of cell lysates with an 18 anti-CXCR4 antibody followed by Western blotting with an anti-phosphotyrosine 19 antibody showed a rapid increase in CXCR4 tyrosine phosphorylation that peaked at 2 20 min and then decreased (Fig. 3b) . Tyrosine-phosphorylated proteins of a similar 21 molecular weight (40 kDa) were observed in HaCaT cells treated with bovine 22 lactoferrin within 5 min, suggesting that lactoferrin induces CXCR4 tyrosine 23
phosphorylation. 24 25
Lactoferrin-induced ubiquitination of CXCR4 26
Upon stimulation by SDF-1, CXCR4 is mono-ubiquitinated, and this modification 27 acts as an endosomal sorting signal that marks the receptor for lysosomal degradation 28 The function of CXCR4 is tightly regulated by cell surface expression, which is 7 regulated by receptor endocytosis, intracellular trafficking, and degradation of 8 endocytosed receptors. We performed a cycloheximide chase assay to determine 9 whether endogeneous CXCR4 undergoes degradation in response to bovine lactoferrin 10 stimulation. In the absence of an agonist, a modest reduction in immunoreactive 11 CXCR4 was observed in cycloheximide-treated HaCaT keratinocytes. In the presence 12 of bovine lactoferrin (10 µM) or SDF-1 (100 ng/ml), CXCR4 underwent significant 13 degradation following 3 or 6 hr of agonist treatment (Fig. 4) . 14 15
Discussion 16
Previous studies show that lactoferrin inhibits X4-tropic HIV infection by inhibiting 17 attachment of the viral envelope protein gp120 to CXCR4 on the surface of target cells 18 (Berkhout et al. 2002; Berkhout et al. 2004; Saidi et al. 2006) . Therefore, we speculated 19 that CXCR4 behaves as a lactoferrin receptor. Here, we present evidence of a novel role 20 for CXCR4 as a receptor for lactoferrin that mediates lactoferrin-induced Akt activation. 21
The best characterized receptor for lactoferrin-induced cell signaling is LRP-1 (Suzuki 22
et al. 2005). However, lactoferrin-induced Akt activation is not inhibited by receptor 23 associated protein (RAP), which inhibits ligand interactions with LRP, suggesting that 24
LRP-1 is not responsible for lactoferrin-induced Akt activation (Grey et al. 2006). In 25
Caco-2 human intestinal cells, intelectin-1 is responsible for lactoferrin uptake and 26 activation of ERK1/2 signaling in response to lactoferrin (Jiang et al. 2011) . 27
Nevertheless, lactoferrin-induced activation of Akt was not inhibited by RNA silencing 28 of intelectin-1 (Jiang and Lönnerdal 2012). Therefore, a receptor other than LRP-1 or 29 intelectin-1 must be responsible for lactoferrin-induced Akt activation. 30
Lactoferrin-induced Akt activation was inhibited by a CXCR4 antagonist (AMD3100) 31
or a CXCR4-neutralizing antibody (Fig. 2b, 2c and 5), suggesting that CXCR4 plays anD r a f t keratinocytes and Caco-2 intestinal cells, lactoferrin-induced Akt activation was not 1 inhibited by treatment with a CXCR4 antagonist in normal human dermal fibroblasts 2 (data not shown), indicating that the role of CXCR4 in Akt activation is cell-type 3 specific, and suggesting the involvement of a different receptor in lactoferrin-induced 4
Akt activation in dermal fibroblasts. 5 CXCR4 is an evolutionarily conserved protein (Rossi and Zlotnik 2000). CXCR4 6 expression is heterogeneous among different cells of the leukocyte lineage, suggesting 7 that CXCR4 may act as a lactoferrin receptor in cells other than keratinocytes and 8 intestinal cells. The promoting effect of lactoferrin on CXCR4 expression is reported in 9 dendritic cells (Spadaro et al. 2008 ). In addition to Akt activation, CXCR4 is also 10 involved in STAT3 activation (Vila-Coro et al. 1999 ). Further study is required to 11 explore the role of CXCR4 as an lactoferrin receptor. 12
We found that lactoferrin increased tyrosine phosphorylation and dimerization of 13 CXCR4 (Fig. 3) . Homo-dimerization of CXCR4 is an initial step for the activation of Yoder 2009). However, we found that a CXCR4 antagonist (AMD3100) increased 21 ERK1/2 phosphorylation in lactoferrin-treated HaCaT keratinocytes (Fig. 2b) , 22
suggesting that lactoferrin-induced ERK1/2 phosphorylation is mediated by another 23 receptor and lactoferrin inhibits ERK1/2 phosphorylation as a result of CXCR4 binding. 24 Therefore, the functional outcome of CXCR4 activation is likely determined by the 25 specifics of ligand-CXCR4 interaction. 26
Nevertheless, lactoferrin mimicked many aspects of CXCR4 activity induced by SDF-1 27 binding, including receptor dimerization, tyrosine phosphorylation, and 28 mono-ubiquitination (Fig. 3) . Ubiquitination of CXCR4 is a common way of mediating 29 The mechanism through which SDF-1 induces the endocytosis and degradation of 3 CXCR4 is not fully understood. A region in the extracellular N-terminal domain of 4 CXCR4 is responsible for the initial binding of SDF-1, and this is followed by its 5 interaction with extracellular loops and the membrane-spanning domains of CXCR4 6 (Brelot et al. 2000) . This second interaction is required for the activation of intracellular 7 signaling. HIV-1 infection via CXCR4 seems to be dependent on interaction of SDF-1 8 with the residues of CXCR4 involved in activation of intracellular signaling (Brelot et 9 al. 2000) . It will be valuable to characterize the lactoferrin-binding site of CXCR4 and 10 assess its binding properties. 11
In this study, we found that the amount of CXCR4-containing lipoparticles 12 bound by lactoferrin was 1.7 times the number of null lipoparticles bound 13 (Fig. 1) , suggesting that bovine lactoferrin interacts with the extracellular domain of 14 SDF-1 blocks CXCR4-dependent HIV-1 infection in T-lymphocytes (Bleul et al. 1996; 19 Oberlin et al. 1996; Valenzuela-Fernández et al. 2001 ). This inhibitory effect of SDF-1 20 is due not only to competitive interaction of SDF-1 and gp120 with CXCR4, but also to 21 the down-regulation of CXCR4 at the cell surface by induction of CXCR4 endocytosis (Amara et al. 1997) . We found here that lactoferrin also enhanced CXCR4 23 down-regulation by enhancing CXCR4 turnover (Fig. 4) . This lactoferrin-induced 24 
